199 related articles for article (PubMed ID: 10914317)
21. Properties of sustained-release tablets prepared by hot-melt extrusion.
Zhang F; McGinity JW
Pharm Dev Technol; 1999 May; 4(2):241-50. PubMed ID: 10231885
[TBL] [Abstract][Full Text] [Related]
22. The manufacture and characterisation of hot-melt extruded enteric tablets.
Andrews GP; Jones DS; Diak OA; McCoy CP; Watts AB; McGinity JW
Eur J Pharm Biopharm; 2008 May; 69(1):264-73. PubMed ID: 18164604
[TBL] [Abstract][Full Text] [Related]
23. Development of a HPMC-based controlled release formulation with hot melt extrusion (HME).
Ma D; Djemai A; Gendron CM; Xi H; Smith M; Kogan J; Li L
Drug Dev Ind Pharm; 2013 Jul; 39(7):1070-83. PubMed ID: 22803806
[TBL] [Abstract][Full Text] [Related]
24. Chitosan and sodium sulfate as excipients in the preparation of prolonged release theophylline tablets.
Alsarra IA; El-Bagory I; Bayomi MA
Drug Dev Ind Pharm; 2005 May; 31(4-5):385-95. PubMed ID: 16093204
[TBL] [Abstract][Full Text] [Related]
25. Formulation and characterization of a compacted multiparticulate system for modified release of water-soluble drugs--Part II theophylline and cimetidine.
Cantor SL; Hoag SW; Augsburger LL
Drug Dev Ind Pharm; 2009 May; 35(5):568-82. PubMed ID: 18979306
[TBL] [Abstract][Full Text] [Related]
26. Exploratory studies in heat-assisted continuous twin-screw dry granulation: A novel alternative technique to conventional dry granulation.
Kallakunta VR; Patil H; Tiwari R; Ye X; Upadhye S; Vladyka RS; Sarabu S; Kim DW; Bandari S; Repka MA
Int J Pharm; 2019 Jan; 555():380-393. PubMed ID: 30458256
[TBL] [Abstract][Full Text] [Related]
27. Preparation and evaluation of ketoprofen hot-melt extruded enteric and sustained-release tablets.
Yang R; Wang Y; Zheng X; Meng J; Tang X; Zhang X
Drug Dev Ind Pharm; 2008 Jan; 34(1):83-9. PubMed ID: 18214759
[TBL] [Abstract][Full Text] [Related]
28. Impact of formulation and process variables on solid-state stability of theophylline in controlled release formulations.
Korang-Yeboah M; Rahman Z; Shah D; Mohammad A; Wu S; Siddiqui A; Khan MA
Int J Pharm; 2016 Feb; 499(1-2):20-28. PubMed ID: 26688036
[TBL] [Abstract][Full Text] [Related]
29. Solid-state plasticization of an acrylic polymer with chlorpheniramine maleate and triethyl citrate.
Zhu Y; Shah NH; Malick AW; Infeld MH; McGinity JW
Int J Pharm; 2002 Jul; 241(2):301-10. PubMed ID: 12100857
[TBL] [Abstract][Full Text] [Related]
30. Ethylene vinyl acetate as matrix for oral sustained release dosage forms produced via hot-melt extrusion.
Almeida A; Possemiers S; Boone MN; De Beer T; Quinten T; Van Hoorebeke L; Remon JP; Vervaet C
Eur J Pharm Biopharm; 2011 Feb; 77(2):297-305. PubMed ID: 21168487
[TBL] [Abstract][Full Text] [Related]
31. Melt-Extruded Eudragit® FS-Based Granules for Colonic Drug Delivery.
Zhang F
AAPS PharmSciTech; 2016 Feb; 17(1):56-67. PubMed ID: 26162974
[TBL] [Abstract][Full Text] [Related]
32. Use of surfactants as plasticizers in preparing solid dispersions of poorly soluble API: stability testing of selected solid dispersions.
Ghebremeskel AN; Vemavarapu C; Lodaya M
Pharm Res; 2006 Aug; 23(8):1928-36. PubMed ID: 16871443
[TBL] [Abstract][Full Text] [Related]
33. Solid lipid extrudates as sustained-release matrices: the effect of surface structure on drug release properties.
Reitz C; Strachan C; Kleinebudde P
Eur J Pharm Sci; 2008 Nov; 35(4):335-43. PubMed ID: 18765281
[TBL] [Abstract][Full Text] [Related]
34. Hydrophilic matrices: application of Placket-Burman screening design to model the effect of POLYOX-carbopol blends on drug release.
El-Malah Y; Nazzal S
Int J Pharm; 2006 Feb; 309(1-2):163-70. PubMed ID: 16413978
[TBL] [Abstract][Full Text] [Related]
35. Melt extruded helical waxy matrices as a new sustained drug delivery system.
Hasa D; Perissutti B; Grassi M; Zacchigna M; Pagotto M; Lenaz D; Kleinebudde P; Voinovich D
Eur J Pharm Biopharm; 2011 Nov; 79(3):592-600. PubMed ID: 21827851
[TBL] [Abstract][Full Text] [Related]
36. Dissolution enhancement of poorly water-soluble APIs processed by hot-melt extrusion using hydrophilic polymers.
Maniruzzaman M; Rana MM; Boateng JS; Mitchell JC; Douroumis D
Drug Dev Ind Pharm; 2013 Feb; 39(2):218-27. PubMed ID: 22452601
[TBL] [Abstract][Full Text] [Related]
37. Effect of melt extrudability and melt binding efficiency of polyvinyl caprolactam polyvinyl acetate polyethylene glycol graft copolymer (Soluplus®) on release pattern of hydrophilic and high dose drugs.
Tousif Ayyub K; Moravkar K; Maniruzzaman M; Amin P
Mater Sci Eng C Mater Biol Appl; 2019 Jun; 99():563-574. PubMed ID: 30889730
[TBL] [Abstract][Full Text] [Related]
38. Application of mixtures of polymeric carriers for dissolution enhancement of fenofibrate using hot-melt extrusion.
Kalivoda A; Fischbach M; Kleinebudde P
Int J Pharm; 2012 Jun; 429(1-2):58-68. PubMed ID: 22440149
[TBL] [Abstract][Full Text] [Related]
39. Drug dispersion degree and drug dissolution rate in Hybrane S1200-based instant-release matricial particles prepared by hot melt extrusion.
Ravina-Eirin E; Gomez-Amoza JL; Martínez-Pacheco R
Drug Dev Ind Pharm; 2015 Jun; 41(6):1000-5. PubMed ID: 24874791
[TBL] [Abstract][Full Text] [Related]
40. Solid lipid extrusion of sustained release dosage forms.
Reitz C; Kleinebudde P
Eur J Pharm Biopharm; 2007 Sep; 67(2):440-8. PubMed ID: 17481868
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
